Boston Scientific Corp Stock Today
BSX Stock | USD 68.49 0.13 0.19% |
Performance22 of 100
| Odds Of DistressLess than 1
|
Boston Scientific is trading at 68.49 as of the 28th of March 2024; that is -0.19 percent decrease since the beginning of the trading day. The stock's open price was 68.62. Boston Scientific has a very small chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Equity ratings for Boston Scientific Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of April 2022 and ending today, the 28th of March 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 18th of May 1992 | Category Healthcare | Classification Health Care |
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. Boston Scientific operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 1.47 B outstanding shares of which 11.48 M shares are currently shorted by investors with about 1.75 days to cover. More on Boston Scientific Corp
Moving together with Boston Stock
0.62 | COO | Cooper Companies Financial Report 6th of June 2024 | PairCorr |
Moving against Boston Stock
0.89 | PHG | Koninklijke Philips Financial Report 22nd of April 2024 | PairCorr |
0.87 | PIIIW | P3 Health Partners | PairCorr |
0.82 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.81 | MASS | 908 Devices Financial Report 14th of May 2024 | PairCorr |
0.77 | NEOG | Neogen Report 4th of April 2024 | PairCorr |
0.66 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
0.62 | MBOT | Microbot Medical Earnings Call Tomorrow | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 24th of April 2024
Boston Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Boston Scientific's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Boston Scientific or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Boston Scientific's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Boston Scientific's managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
Chairman | Michael Mahoney | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, Healthcare, Obamacare Repeal, Macroaxis Picks, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Excise Tax Activities | Animal Testing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Analyst Recommendation Analysts covering Boston Scientific report their recommendations after researching Boston Scientific's financial statements, talking to executives and customers, or listening in on Boston Scientific's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Boston Scientific Corp. The Boston consensus assessment is calculated by taking the average forecast from all of the analysts covering Boston Scientific. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength Based on the measurements of operating efficiency obtained from Boston Scientific's historical financial statements, Boston Scientific Corp is performing exceptionally good at this time. It has a great probability to report excellent financial results in April. Financial strength of Boston Scientific Corp is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Boston Scientific's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Boston Scientific's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. Boston Scientific's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Boston Scientific's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest. Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Boston Scientific's financial leverage. It provides some insight into what part of Boston Scientific's total assets is financed by creditors.
|
Boston Scientific Corp (BSX) is traded on New York Stock Exchange in USA. It is located in 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 and employs 48,000 people. Boston Scientific is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 100.86 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Boston Scientific's market, we take the total number of its shares issued and multiply it by Boston Scientific's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Boston Scientific Corp runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 1.47 B outstanding shares of which 11.48 M shares are currently shorted by investors with about 1.75 days to cover.
Boston Scientific Corp has about 928 M in cash with 2.5 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.24.
Check Boston Scientific Probability Of Bankruptcy
Ownership AllocationBoston Scientific Corp retains a total of 1.47 Billion outstanding shares. The majority of Boston Scientific Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Boston Scientific Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Boston Scientific. Please pay attention to any change in the institutional holdings of Boston Scientific Corp as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Boston Ownership Details
Boston Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Boston Scientific jumping above the current price in 90 days from now is about 10.61%. The Boston Scientific Corp probability density function shows the probability of Boston Scientific stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Boston Scientific has a beta of 0.1897 suggesting as returns on the market go up, Boston Scientific average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Boston Scientific Corp will be expected to be much smaller as well. Additionally, boston Scientific Corp has an alpha of 0.2792, implying that it can generate a 0.28 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Boston Scientific to move above the current price in 90 days from now is about 10.61 (This Boston Scientific Corp probability density function shows the probability of Boston Stock to fall within a particular range of prices over 90 days) .
Boston Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Boston Scientific that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Boston Scientific's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Boston Scientific's value.Instituion | Recorded On | Shares | |
Bollard Group Llc | 2023-12-31 | 22.4 M | |
Citadel Advisors Llc | 2023-09-30 | 21.2 M | |
Dz Bank Ag Deutsche Zentral-genossenschaftsbank Frankfurt Am Main | 2023-12-31 | 21.1 M | |
Hhg Plc | 2023-12-31 | 19.5 M | |
Morgan Stanley - Brokerage Accounts | 2023-12-31 | 18.8 M | |
Artisan Partners Limited Partnership | 2023-12-31 | 17.2 M | |
Bank Of New York Mellon Corp | 2023-12-31 | 17 M | |
Norges Bank | 2023-12-31 | 16.1 M | |
Northern Trust Corp | 2023-12-31 | 13.7 M | |
Fmr Inc | 2023-12-31 | 138.3 M | |
Blackrock Inc | 2023-12-31 | 126.6 M |
Boston Scientific Historical Income Statement
Boston Scientific Corp Income Statement is one of the three primary financial statements used for reporting Boston's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Boston Scientific Corp revenue and expense. Boston Scientific Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Boston Scientific's Income Before Tax is fairly stable compared to the past year. Net Income is likely to rise to about 1.7 B in 2024, whereas Interest Expense is likely to drop slightly above 193.9 M in 2024. View More FundamentalsBoston Stock Against Markets
Picking the right benchmark for Boston Scientific stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Boston Scientific stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Boston Scientific is critical whether you are bullish or bearish towards Boston Scientific Corp at a given time. Please also check how Boston Scientific's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Boston Scientific without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
All Next | Launch Module |
Boston Scientific Corporate Directors
Boston Scientific corporate directors refer to members of a Boston Scientific board of directors. The board of directors generally takes responsibility for the Boston Scientific's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Boston Scientific's board members must vote for the resolution. The Boston Scientific board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.Edward Ludwig | Lead Independent Director | Profile | |
Donna James | Independent Director | Profile | |
Stephen MacMillan | Independent Director | Profile | |
Ellen Zane | Independent Director | Profile |
How to buy Boston Stock?
Before investing in Boston Scientific, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Boston Scientific. To buy Boston Scientific stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Boston Scientific. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Boston Scientific stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Boston Scientific Corp stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Boston Scientific Corp stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Boston Scientific Corp, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Boston Stock please use our How to Invest in Boston Scientific guide.
Already Invested in Boston Scientific Corp?
The danger of trading Boston Scientific Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Boston Scientific is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Boston Scientific. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Boston Scientific Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Boston Scientific Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Boston Scientific's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Boston Scientific Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Boston Scientific Corp Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Boston Stock analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.856 | Earnings Share 1.07 | Revenue Per Share 9.8 | Quarterly Revenue Growth 0.149 | Return On Assets 0.0447 |
The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.